Bruker Corporation (NASDAQ: BRKR) Stock Competitors & Peer Comparison
See BRKR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BRKR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRKR | $58.44 | -0.98% | 9B | 29.85 | $1.99 | +0.34% |
| ABT | $108.99 | -1.34% | 188.2B | 20.88 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $94.38 | +2.39% | 119.2B | 16.84 | $5.53 | +3.08% |
| SYK | $304.31 | -2.52% | 118.1B | 23.00 | $13.39 | +1.13% |
| BSX | $48.01 | -0.74% | 69.8B | 15.15 | $3.10 | N/A |
| EW | $90.06 | -0.84% | 51.7B | 33.25 | $2.70 | N/A |
| DXCM | $88.04 | -1.84% | 33.9B | 35.18 | $2.55 | N/A |
| GEHC | $68.94 | -2.30% | 31.5B | 15.29 | $4.56 | +0.20% |
| PHG | $25.93 | -1.67% | 25.5B | 14.88 | $1.75 | +3.80% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
BRKR vs ABT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ABT has a market cap of 188.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ABT trades at $108.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ABT's P/E ratio is 20.88. In terms of profitability, BRKR's ROE is -0.03%, compared to ABT's ROE of +0.11%. Regarding short-term risk, BRKR is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
BRKR vs BSX-PA Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, BRKR is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
BRKR vs MDT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MDT has a market cap of 119.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while MDT trades at $94.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas MDT's P/E ratio is 16.84. In terms of profitability, BRKR's ROE is -0.03%, compared to MDT's ROE of +0.14%. Regarding short-term risk, BRKR is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
BRKR vs SYK Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SYK has a market cap of 118.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SYK trades at $304.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SYK's P/E ratio is 23.00. In terms of profitability, BRKR's ROE is -0.03%, compared to SYK's ROE of +0.16%. Regarding short-term risk, BRKR is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
BRKR vs BSX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSX has a market cap of 69.8B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BSX trades at $48.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BSX's P/E ratio is 15.15. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX's ROE of +0.15%. Regarding short-term risk, BRKR is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
BRKR vs EW Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while EW trades at $90.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas EW's P/E ratio is 33.25. In terms of profitability, BRKR's ROE is -0.03%, compared to EW's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
BRKR vs DXCM Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, DXCM has a market cap of 33.9B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while DXCM trades at $88.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas DXCM's P/E ratio is 35.18. In terms of profitability, BRKR's ROE is -0.03%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, BRKR is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
BRKR vs GEHC Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, GEHC has a market cap of 31.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while GEHC trades at $68.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas GEHC's P/E ratio is 15.29. In terms of profitability, BRKR's ROE is -0.03%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
BRKR vs PHG Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PHG has a market cap of 25.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PHG trades at $25.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PHG's P/E ratio is 14.88. In terms of profitability, BRKR's ROE is -0.03%, compared to PHG's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
BRKR vs ZBH Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ZBH has a market cap of 19.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ZBH trades at $98.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ZBH's P/E ratio is 11.67. In terms of profitability, BRKR's ROE is -0.03%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
BRKR vs ABMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BRKR's ROE is -0.03%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
BRKR vs PEN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PEN trades at $322.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PEN's P/E ratio is 83.90. In terms of profitability, BRKR's ROE is -0.03%, compared to PEN's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
BRKR vs SWAV Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BRKR's ROE is -0.03%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, BRKR is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
BRKR vs SNN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SNN has a market cap of 12.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SNN trades at $28.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SNN's P/E ratio is 13.50. In terms of profitability, BRKR's ROE is -0.03%, compared to SNN's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
BRKR vs ALGN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ALGN trades at $158.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ALGN's P/E ratio is 14.57. In terms of profitability, BRKR's ROE is -0.03%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, BRKR is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ALGN's competition here
Glaukos Corporation (NYSE: GKOS)
BRKR vs GKOS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while GKOS trades at $178.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas GKOS's P/E ratio is -209.80. In terms of profitability, BRKR's ROE is -0.03%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, BRKR is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check GKOS's competition here
Globus Medical, Inc. (NYSE: GMED)
BRKR vs GMED Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, GMED has a market cap of 10.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while GMED trades at $78.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas GMED's P/E ratio is 17.59. In terms of profitability, BRKR's ROE is -0.03%, compared to GMED's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check GMED's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BRKR vs BIO Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BIO trades at $385.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BIO's P/E ratio is 41.79. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO's ROE of +0.03%. Regarding short-term risk, BRKR is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
BRKR vs BIO-B Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, BRKR is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BIO-B's competition here
Insulet Corp. (NASDAQ: PODD)
BRKR vs PODD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PODD has a market cap of 10.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PODD trades at $146.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PODD's P/E ratio is 25.65. In terms of profitability, BRKR's ROE is -0.03%, compared to PODD's ROE of +0.27%. Regarding short-term risk, BRKR is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
BRKR vs MASI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas MASI's P/E ratio is 44.43. In terms of profitability, BRKR's ROE is -0.03%, compared to MASI's ROE of +0.09%. Regarding short-term risk, BRKR is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKRP)
BRKR vs BRKRP Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BRKRP trades at $432.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BRKRP's P/E ratio is 238.04. In terms of profitability, BRKR's ROE is -0.03%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, BRKR is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
BRKR vs NARI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NARI's P/E ratio is -59.24. In terms of profitability, BRKR's ROE is -0.03%, compared to NARI's ROE of -0.00%. Regarding short-term risk, BRKR is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
BRKR vs HAE Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while HAE trades at $103.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas HAE's P/E ratio is 20.52. In terms of profitability, BRKR's ROE is -0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
BRKR vs LIVN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while LIVN trades at $82.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas LIVN's P/E ratio is 19.29. In terms of profitability, BRKR's ROE is -0.03%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
BRKR vs ITGR Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ITGR trades at $126.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ITGR's P/E ratio is 19.76. In terms of profitability, BRKR's ROE is -0.03%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, BRKR is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
BRKR vs IRTC Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while IRTC trades at $122.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas IRTC's P/E ratio is -287.05. In terms of profitability, BRKR's ROE is -0.03%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, BRKR is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
BRKR vs AXNX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BRKR's ROE is -0.03%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
BRKR vs TMDX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while TMDX trades at $88.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas TMDX's P/E ratio is 44.15. In terms of profitability, BRKR's ROE is -0.03%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, BRKR is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
BRKR vs NEOG Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NEOG trades at $11.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NEOG's P/E ratio is 41.57. In terms of profitability, BRKR's ROE is -0.03%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, BRKR is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
BRKR vs AXGN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AXGN trades at $48.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AXGN's P/E ratio is 123.95. In terms of profitability, BRKR's ROE is -0.03%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, BRKR is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
BRKR vs UFPT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while UFPT trades at $287.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas UFPT's P/E ratio is 29.27. In terms of profitability, BRKR's ROE is -0.03%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, BRKR is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
BRKR vs ESTA Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ESTA trades at $74.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ESTA's P/E ratio is -57.38. In terms of profitability, BRKR's ROE is -0.03%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, BRKR is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
BRKR vs NUVA Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BRKR's ROE is -0.03%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BRKR is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
BRKR vs NVCR Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NVCR trades at $17.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NVCR's P/E ratio is -13.57. In terms of profitability, BRKR's ROE is -0.03%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, BRKR is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check NVCR's competition here
Butterfly Network, Inc. (NYSE: BFLY)
BRKR vs BFLY Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BFLY trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BFLY's P/E ratio is -30.35. In terms of profitability, BRKR's ROE is -0.03%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, BRKR is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BFLY's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
BRKR vs INSP Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while INSP trades at $63.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas INSP's P/E ratio is 27.34. In terms of profitability, BRKR's ROE is -0.03%, compared to INSP's ROE of +0.18%. Regarding short-term risk, BRKR is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
BRKR vs CNMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CNMD trades at $49.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CNMD's P/E ratio is 10.84. In terms of profitability, BRKR's ROE is -0.03%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
BRKR vs ATEC Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ATEC trades at $9.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ATEC's P/E ratio is -155.50. In terms of profitability, BRKR's ROE is -0.03%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, BRKR is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ATEC's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
BRKR vs TNDM Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while TNDM trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas TNDM's P/E ratio is -21.97. In terms of profitability, BRKR's ROE is -0.03%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, BRKR is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
BRKR vs HSKA Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BRKR's ROE is -0.03%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BRKR is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
BRKR vs IART Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while IART trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas IART's P/E ratio is 6.97. In terms of profitability, BRKR's ROE is -0.03%, compared to IART's ROE of -0.01%. Regarding short-term risk, BRKR is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
BRKR vs AORT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AORT trades at $25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AORT's P/E ratio is 42.67. In terms of profitability, BRKR's ROE is -0.03%, compared to AORT's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AORT's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
BRKR vs PRCT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PRCT trades at $22.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PRCT's P/E ratio is -11.02. In terms of profitability, BRKR's ROE is -0.03%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, BRKR is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
BRKR vs AVNS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AVNS's P/E ratio is 27.77. In terms of profitability, BRKR's ROE is -0.03%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, BRKR is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
BRKR vs LMRI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while LMRI trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas LMRI's P/E ratio is -23.15. In terms of profitability, BRKR's ROE is -0.03%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, BRKR is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
BRKR vs SILK Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SILK's P/E ratio is -18.96. In terms of profitability, BRKR's ROE is -0.03%, compared to SILK's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SILK's competition here
Enovis Corporation (NYSE: ENOV)
BRKR vs ENOV Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ENOV trades at $18.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ENOV's P/E ratio is 5.55. In terms of profitability, BRKR's ROE is -0.03%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, BRKR is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ENOV's competition here
IRadimed Corporation (NASDAQ: IRMD)
BRKR vs IRMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while IRMD trades at $84.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas IRMD's P/E ratio is 43.51. In terms of profitability, BRKR's ROE is -0.03%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BRKR is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
BRKR vs FNA Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas FNA's P/E ratio is -19.83. In terms of profitability, BRKR's ROE is -0.03%, compared to FNA's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
BRKR vs BVS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BVS has a market cap of 972.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BVS trades at $14.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BVS's P/E ratio is 18.89. In terms of profitability, BRKR's ROE is -0.03%, compared to BVS's ROE of +0.28%. Regarding short-term risk, BRKR is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
BRKR vs CBLL Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CBLL has a market cap of 932.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CBLL trades at $24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CBLL's P/E ratio is -13.96. In terms of profitability, BRKR's ROE is -0.03%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, BRKR is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
BRKR vs BBNX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BBNX has a market cap of 896.2M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BBNX trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BBNX's P/E ratio is -12.07. In terms of profitability, BRKR's ROE is -0.03%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, BRKR is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BBNX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
BRKR vs AHCO Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AHCO has a market cap of 873.5M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AHCO trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AHCO's P/E ratio is 13.10. In terms of profitability, BRKR's ROE is -0.03%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, BRKR is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AHCO's competition here
InMode Ltd. (NASDAQ: INMD)
BRKR vs INMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INMD has a market cap of 853M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while INMD trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas INMD's P/E ratio is 10.31. In terms of profitability, BRKR's ROE is -0.03%, compared to INMD's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
BRKR vs AVR Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AVR has a market cap of 847.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while AVR trades at $9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas AVR's P/E ratio is -4.49. In terms of profitability, BRKR's ROE is -0.03%, compared to AVR's ROE of -0.78%. Regarding short-term risk, BRKR is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
BRKR vs CSII Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CSII's P/E ratio is -20.83. In terms of profitability, BRKR's ROE is -0.03%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BRKR is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
BRKR vs SIBN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SIBN has a market cap of 826.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SIBN trades at $18.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SIBN's P/E ratio is -54.82. In terms of profitability, BRKR's ROE is -0.03%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, BRKR is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SIBN's competition here
Varex Imaging Corporation (NASDAQ: VREX)
BRKR vs VREX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, VREX has a market cap of 779.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while VREX trades at $18.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas VREX's P/E ratio is 19.49. In terms of profitability, BRKR's ROE is -0.03%, compared to VREX's ROE of +0.05%. Regarding short-term risk, BRKR is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
BRKR vs SSII Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SSII has a market cap of 678.4M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SSII trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SSII's P/E ratio is -66.12. In terms of profitability, BRKR's ROE is -0.03%, compared to SSII's ROE of -0.27%. Regarding short-term risk, BRKR is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
BRKR vs SRDX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SRDX's P/E ratio is -34.66. In terms of profitability, BRKR's ROE is -0.03%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
BRKR vs CTKB Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CTKB has a market cap of 607M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CTKB trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CTKB's P/E ratio is -24.90. In terms of profitability, BRKR's ROE is -0.03%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, BRKR is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CTKB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
BRKR vs KIDS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, KIDS has a market cap of 580.2M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while KIDS trades at $22.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas KIDS's P/E ratio is -19.14. In terms of profitability, BRKR's ROE is -0.03%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, BRKR is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
BRKR vs APEN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas APEN's P/E ratio is -9.43. In terms of profitability, BRKR's ROE is -0.03%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
BRKR vs DCTH Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, DCTH has a market cap of 568.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while DCTH trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas DCTH's P/E ratio is 1648.00. In terms of profitability, BRKR's ROE is -0.03%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, BRKR is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
BRKR vs ZIMV Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, BRKR's ROE is -0.03%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
BRKR vs CERS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CERS has a market cap of 517.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CERS trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CERS's P/E ratio is -51.30. In terms of profitability, BRKR's ROE is -0.03%, compared to CERS's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
BRKR vs NPCE Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NPCE has a market cap of 502.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NPCE trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NPCE's P/E ratio is -25.88. In terms of profitability, BRKR's ROE is -0.03%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, BRKR is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NPCE's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
BRKR vs TCMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TCMD has a market cap of 496.5M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while TCMD trades at $21.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas TCMD's P/E ratio is 20.38. In terms of profitability, BRKR's ROE is -0.03%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, BRKR is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
BRKR vs SGHT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SGHT has a market cap of 456M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SGHT trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SGHT's P/E ratio is -14.96. In terms of profitability, BRKR's ROE is -0.03%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, BRKR is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
BRKR vs CARL Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CARL has a market cap of 421.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CARL trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CARL's P/E ratio is -10.85. In terms of profitability, BRKR's ROE is -0.03%, compared to CARL's ROE of -0.38%. Regarding short-term risk, BRKR is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CARL's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
BRKR vs CLPT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CLPT has a market cap of 421.4M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CLPT trades at $14.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CLPT's P/E ratio is -11.91. In terms of profitability, BRKR's ROE is -0.03%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, BRKR is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
BRKR vs SENS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SENS has a market cap of 413.8M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SENS trades at $9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SENS's P/E ratio is -4.44. In terms of profitability, BRKR's ROE is -0.03%, compared to SENS's ROE of -1.66%. Regarding short-term risk, BRKR is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SENS's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
BRKR vs PACB Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PACB has a market cap of 403.8M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PACB trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PACB's P/E ratio is -3.17. In terms of profitability, BRKR's ROE is -0.03%, compared to PACB's ROE of -49.62%. Regarding short-term risk, BRKR is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PACB's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
BRKR vs OFIX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, OFIX has a market cap of 376.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while OFIX trades at $9.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas OFIX's P/E ratio is -6.06. In terms of profitability, BRKR's ROE is -0.03%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, BRKR is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
BRKR vs CATX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CATX has a market cap of 354.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CATX trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CATX's P/E ratio is -2.34. In terms of profitability, BRKR's ROE is -0.03%, compared to CATX's ROE of -0.42%. Regarding short-term risk, BRKR is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
BRKR vs TMCI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TMCI has a market cap of 316.6M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while TMCI trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas TMCI's P/E ratio is -5.19. In terms of profitability, BRKR's ROE is -0.03%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, BRKR is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TMCI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
BRKR vs SMLR Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas SMLR's P/E ratio is 3.92. In terms of profitability, BRKR's ROE is -0.03%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
BRKR vs TLSI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TLSI has a market cap of 306.6M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while TLSI trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas TLSI's P/E ratio is -2.96. In terms of profitability, BRKR's ROE is -0.03%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, BRKR is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
BRKR vs CV Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CV has a market cap of 298.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while CV trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas CV's P/E ratio is -2.39. In terms of profitability, BRKR's ROE is -0.03%, compared to CV's ROE of -1.78%. Regarding short-term risk, BRKR is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
BRKR vs RCEL Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, RCEL has a market cap of 271.8M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while RCEL trades at $11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas RCEL's P/E ratio is -7.60. In terms of profitability, BRKR's ROE is -0.03%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, BRKR is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check RCEL's competition here
RxSight, Inc. (NASDAQ: RXST)
BRKR vs RXST Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, RXST has a market cap of 270.7M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while RXST trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas RXST's P/E ratio is -5.79. In terms of profitability, BRKR's ROE is -0.03%, compared to RXST's ROE of -0.17%. Regarding short-term risk, BRKR is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
BRKR vs PROF Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PROF has a market cap of 247.1M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while PROF trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas PROF's P/E ratio is -6.94. In terms of profitability, BRKR's ROE is -0.03%, compared to PROF's ROE of -0.56%. Regarding short-term risk, BRKR is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
BRKR vs INFU Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INFU has a market cap of 245.4M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while INFU trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas INFU's P/E ratio is 29.66. In terms of profitability, BRKR's ROE is -0.03%, compared to INFU's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
BRKR vs MGRM Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas MGRM's P/E ratio is -12.00. In terms of profitability, BRKR's ROE is -0.03%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
BRKR vs ELMD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ELMD has a market cap of 228.4M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ELMD trades at $27.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ELMD's P/E ratio is 21.06. In terms of profitability, BRKR's ROE is -0.03%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, BRKR is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
BRKR vs NVRO Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BRKR's ROE is -0.03%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BRKR is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NVRO's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
BRKR vs BSGM Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas BSGM's P/E ratio is -5.81. In terms of profitability, BRKR's ROE is -0.03%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, BRKR is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
BRKR vs STIM Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, STIM has a market cap of 189.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while STIM trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas STIM's P/E ratio is -6.18. In terms of profitability, BRKR's ROE is -0.03%, compared to STIM's ROE of -1.51%. Regarding short-term risk, BRKR is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
BRKR vs LUCD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LUCD has a market cap of 181.5M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while LUCD trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas LUCD's P/E ratio is -2.57. In terms of profitability, BRKR's ROE is -0.03%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, BRKR is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
BRKR vs MDGS Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas MDGS's P/E ratio is -0.27. In terms of profitability, BRKR's ROE is -0.03%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, BRKR is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
BRKR vs QIPT Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas QIPT's P/E ratio is -15.87. In terms of profitability, BRKR's ROE is -0.03%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
BRKR vs FOCL Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, FOCL has a market cap of 156.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while FOCL trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas FOCL's P/E ratio is -4.03. In terms of profitability, BRKR's ROE is -0.03%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, BRKR is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
BRKR vs QSI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, QSI has a market cap of 153.1M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while QSI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas QSI's P/E ratio is -1.68. In terms of profitability, BRKR's ROE is -0.03%, compared to QSI's ROE of -0.47%. Regarding short-term risk, BRKR is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
BRKR vs INGN Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INGN has a market cap of 147.6M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while INGN trades at $5.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas INGN's P/E ratio is -5.99. In terms of profitability, BRKR's ROE is -0.03%, compared to INGN's ROE of -0.13%. Regarding short-term risk, BRKR is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
BRKR vs QTRX Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, QTRX has a market cap of 121.5M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while QTRX trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas QTRX's P/E ratio is -1.02. In terms of profitability, BRKR's ROE is -0.03%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, BRKR is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
BRKR vs ICAD Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas ICAD's P/E ratio is -20.37. In terms of profitability, BRKR's ROE is -0.03%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, BRKR is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
BRKR vs LNSR Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LNSR has a market cap of 101.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while LNSR trades at $8.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas LNSR's P/E ratio is 8.42. In terms of profitability, BRKR's ROE is -0.03%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, BRKR is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
BRKR vs HJLI Comparison September 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BRKR is priced at $58.44 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.85, whereas HJLI's P/E ratio is N/A. In terms of profitability, BRKR's ROE is -0.03%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, BRKR is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check HJLI's competition here